Hiroaki Okamoto
Department of Respiratory Medicine
Yokohama Municipal Citizen's Hospital
Yokohama
Japan
Name/email consistency: low
- Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. Okamoto, H., Watanabe, K., Kunikane, H., Yokoyama, A., Kudoh, S., Asakawa, T., Shibata, T., Kunitoh, H., Tamura, T., Saijo, N. Br. J. Cancer (2007)
- A combination chemotherapy of carboplatin and irinotecan with granulocyte colony-stimulating factor (G-CSF) support in elderly patients with small cell lung cancer. Okamoto, H., Naoki, K., Narita, Y., Hida, N., Kunikane, H., Watanabe, K. Lung. Cancer (2006)
- Endobronchial ultrasonography for mediastinal and hilar lymph node metastases of lung cancer. Okamoto, H., Watanabe, K., Nagatomo, A., Kunikane, H., Aono, H., Yamagata, T., Kase, M. Chest (2002)
- Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer. Okamoto, H., Watanabe, K., Nishiwaki, Y., Mori, K., Kurita, Y., Hayashi, I., Masutani, M., Nakata, K., Tsuchiya, S., Isobe, H., Saijo, N. J. Clin. Oncol. (1999)